awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36788133-205E8C86-8304-4EF4-8897-C4E7F3C31A2D
Q36788133-205E8C86-8304-4EF4-8897-C4E7F3C31A2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36788133-205E8C86-8304-4EF4-8897-C4E7F3C31A2D
Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL.
P2860
Q36788133-205E8C86-8304-4EF4-8897-C4E7F3C31A2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36788133-205E8C86-8304-4EF4-8897-C4E7F3C31A2D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ccc12dbd7dd52971574dbb5b5b8d4e67ad9310c2
P2860
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia